Suppr超能文献

澳大利亚一家三级教学医院中使用多潘立酮作为催乳剂的审核。

Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital.

机构信息

Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia, Australia.

出版信息

J Hum Lact. 2013 Feb;29(1):32-7. doi: 10.1177/0890334412459804. Epub 2012 Sep 26.

Abstract

BACKGROUND

Domperidone is often used to promote lactation among women who have difficulty breastfeeding.

OBJECTIVE

To examine prescribing and dispensing practices of domperidone at the Women's and Children's Hospital (WCH), Adelaide.

METHODS

A retrospective audit of domperidone dispensing among women with singleton pregnancies who delivered at the WCH between January 2000 and July 2010 was undertaken. Women dispensed domperidone were identified using WCH pharmacy dispensing records. Maternal and infant clinical data were obtained from the WCH Perinatal Statistics Collection. An audit of paper-based medical records was undertaken for a random sample of 261 mother-child pairs to collect prescribing and additional clinical data.

RESULTS

From 2000 to 2010, 1605 women were dispensed domperidone. There was a steady increase in the percentage of women dispensed domperidone, from < 0.5% in 2000 to > 5% of total WCH pregnancies in 2010. Among women dispensed domperidone, the percentage of women who received > 1 dispensing remained consistent (20%) over time, as did the median number of days (12) from delivery to first dispensing. Multiparous women were more likely to receive domperidone within 3 days following delivery compared to primiparous women (8% vs 4%; P < .01). Most women (80%) received directions to take domperidone according to a standard tapering dosing regimen over 12 days. Notably, 60% of women had no documentation of being assessed by a lactation consultant.

CONCLUSION

From 2000 to 2010, there was a considerable increase in domperidone dispensing. With a lack of clinical evidence to guide use, current practice appears to be based on anecdotal evidence.

摘要

背景

多潘立酮常用于治疗母乳喂养困难的女性。

目的

研究阿德莱德妇女儿童医院(WCH)多潘立酮的开方和配药情况。

方法

对 2000 年 1 月至 2010 年 7 月在 WCH 分娩的单胎妊娠妇女的多潘立酮配药情况进行了回顾性审核。通过 WCH 药房配药记录确定配药的妇女。从 WCH 围产统计资料中获取母婴临床数据。对 261 对母婴随机样本进行了纸质病历审核,以收集开方和其他临床数据。

结果

2000 年至 2010 年,1605 名妇女被配药多潘立酮。配药多潘立酮的妇女比例稳步上升,从 2000 年的<0.5%到 2010 年超过 5%的 WCH 妊娠。在配药多潘立酮的妇女中,接受>1次配药的妇女比例(20%)随时间保持不变,分娩后首次配药的中位数天数(12 天)也保持不变。与初产妇相比,经产妇在分娩后 3 天内接受多潘立酮的可能性更高(8%对 4%;P<0.01)。大多数妇女(80%)按照 12 天标准递减剂量方案服药。值得注意的是,60%的妇女没有接受过哺乳顾问评估的记录。

结论

2000 年至 2010 年,多潘立酮的配药数量显著增加。由于缺乏指导使用的临床证据,目前的做法似乎基于传闻证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验